We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNS icon
176
Varonis Systems
VRNS
$5B
$3.22M 0.04%
83,703
+73,740
+740% +$2.75M
LIN icon
177
Linde
LIN
$226B
$3.16M 0.04%
13,286
+1,387
+12% +$336K
FRPT icon
178
Freshpet
FRPT
$3.22B
$3.15M 0.03%
28,229
+23,802
+538% +$2.42M
PM icon
179
Philip Morris
PM
$295B
$3.13M 0.03%
41,784
-6,646
-14% -$513K
ABBV icon
180
AbbVie
ABBV
$435B
$3.13M 0.03%
35,727
+4,789
+15% +$451K
THC icon
181
Tenet Healthcare
THC
$21.1B
$3.13M 0.03%
127,571
+95,496
+298% +$2.44M
LRCX icon
182
Lam Research
LRCX
$390B
$3.12M 0.03%
94,090
-30,850
-25% -$1.06M
TGNA
183
DELISTED
TEGNA Inc
TGNA
$3.12M 0.03%
265,218
+178,061
+204% +$2.12M
FBT icon
184
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.83B
$3.1M 0.03%
19,696
-15,400
-44% -$2.52M
IWP icon
185
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$3.09M 0.03%
+35,726
New +$3.02M
FISV
186
Fiserv Inc
FISV
$27.9B
$3.09M 0.03%
29,963
+4,008
+15% +$399K
SRNE
187
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3.09M 0.03%
276,714
+189,302
+217% +$1.73M
DON icon
188
WisdomTree US MidCap Dividend Fund
DON
$4.09B
$3.08M 0.03%
106,580
+91,581
+611% +$2.7M
CAT icon
189
Caterpillar
CAT
$387B
$3.08M 0.03%
20,660
+4,222
+26% +$593K
RLI icon
190
RLI Corp
RLI
$5.89B
$3.08M 0.03%
73,570
+45,514
+162% +$2M
MUSA icon
191
Murphy USA
MUSA
$9.61B
$3.05M 0.03%
23,790
+13,963
+142% +$1.85M
WING icon
192
Wingstop
WING
$3.18B
$3.05M 0.03%
22,298
+14,112
+172% +$2.07M
VG
193
DELISTED
Vonage Holdings Corporation
VG
$3.05M 0.03%
297,829
+249,666
+518% +$2.77M
ADEA icon
194
Adeia
ADEA
$3.11B
$3.04M 0.03%
1,000,933
+914,224
+1,054% +$3.38M
CSL icon
195
Carlisle Companies
CSL
$15.4B
$3.04M 0.03%
24,858
+4,550
+22% +$558K
GS icon
196
Goldman Sachs
GS
$303B
$3.03M 0.03%
15,077
+2,548
+20% +$518K
IBM icon
197
IBM
IBM
$224B
$3.03M 0.03%
26,043
+7,884
+43% +$928K
DYNF icon
198
BlackRock US Equity Factor Rotation ETF
DYNF
$40B
$3.03M 0.03%
108,092
+8,371
+8% +$232K
NOBL icon
199
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
$3.02M 0.03%
83,814
+51,366
+158% +$1.84M
ATR icon
200
AptarGroup
ATR
$8.61B
$3.01M 0.03%
26,595
+11,156
+72% +$1.31M
6 7
8
9 10

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.